These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32880166)

  • 1. Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies.
    Liu S; Zhou Y; Hu C; Cai L; Pang M
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43456-43465. PubMed ID: 32880166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Covalent Organic Framework for Combinatorial Antitumor Photodynamic and Photothermal Therapy.
    Guan Q; Zhou LL; Li YA; Li WY; Wang S; Song C; Dong YB
    ACS Nano; 2019 Nov; 13(11):13304-13316. PubMed ID: 31689082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CuS- and BODIPY-loaded nanoscale covalent organic framework for synergetic photodynamic and photothermal therapy.
    Dong XJ; Li WY; Guan Q; Li YA; Dong YB
    Chem Commun (Camb); 2022 Feb; 58(14):2387-2390. PubMed ID: 35081192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A singlet oxygen-storing covalent organic framework for "Afterglow" photodynamic therapy.
    Wang J; Bai L; Huang T; Wang Y; Cheng Z; Liu Q; Su X; Zhao L; Lu F
    J Colloid Interface Sci; 2024 Nov; 673():679-689. PubMed ID: 38901358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor targeted porphyrin-based metal-organic framework for photodynamic and checkpoint blockade immunotherapy.
    Liu Y; Zou B; Yang K; Jiao L; Zhao H; Bai P; Tian Y; Zhang R
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113965. PubMed ID: 38772084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium-engineered covalent organic frameworks for high-efficiency and long-acting cancer therapy.
    Wan X; Wu T; Song L; Pan W; Li N; Tang B
    Chem Commun (Camb); 2021 Jun; 57(50):6145-6148. PubMed ID: 34042122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monodispersed CuSe Sensitized Covalent Organic Framework Photosensitizer with an Enhanced Photodynamic and Photothermal Effect for Cancer Therapy.
    Hu C; Zhang Z; Liu S; Liu X; Pang M
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):23072-23082. PubMed ID: 31252509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
    Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
    ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supra-Carbon Dots Formed by Fe
    Chen Q; Sun S; Lin H; Li Z; Wu A; Liu X; Wu FG; Zhang W
    ACS Appl Bio Mater; 2021 Mar; 4(3):2759-2768. PubMed ID: 35014315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Targeting MoS
    Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SiO
    Sun M; Yang D; Fanqi W; Wang Z; Ji H; Liu Z; Gai S; Zhang F; Yang P
    J Mater Chem B; 2020 Jul; 8(26):5707-5721. PubMed ID: 32510093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pt nanoenzyme- and BODIPY-loaded nanoscale covalent organic framework for relieving intratumoural hypoxia to enhance photodynamic therapy.
    Zhang KX; Wang B; Li WY; Song Y; Song T; Li YA; Dong YB
    Dalton Trans; 2024 Jul; 53(27):11242-11246. PubMed ID: 38919991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy.
    Jiang Y; Lu H; Lei L; Yuan X; Scherman D; Liu Y
    Colloids Surf B Biointerfaces; 2024 Aug; 240():113981. PubMed ID: 38815310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo tumor annihilation by near-infrared photothermal effect of a NiFe
    Gorgizadeh M; Azarpira N; Sattarahmady N
    Colloids Surf B Biointerfaces; 2018 Oct; 170():393-400. PubMed ID: 29945051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
    Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy.
    Bai Z; Huang J; Lu H; Wang N; Li H; Zhu Y
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132207. PubMed ID: 38723823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photothermal Therapy Nanomaterials Boosting Transformation of Fe(III) into Fe(II) in Tumor Cells for Highly Improving Chemodynamic Therapy.
    Nie X; Xia L; Wang HL; Chen G; Wu B; Zeng TY; Hong CY; Wang LH; You YZ
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31735-31742. PubMed ID: 31393101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
    Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
    J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-synthesis strategy to integrate porphyrinic metal-organic frameworks with CuS NPs for synergistic enhanced photo-therapy.
    Hu X; Lu Y; Zhou L; Chen L; Yao T; Liang S; Han J; Dong C; Shi S
    J Mater Chem B; 2020 Feb; 8(5):935-944. PubMed ID: 31912837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.